70 related articles for article (PubMed ID: 19515185)
1. The Role of Magnetic Resonance Imaging in the Management of Esophageal Cancer.
Pellat A; Dohan A; Soyer P; Veziant J; Coriat R; Barret M
Cancers (Basel); 2022 Feb; 14(5):. PubMed ID: 35267447
[TBL] [Abstract][Full Text] [Related]
2. Preoperative Prediction of Pathologic Response to Neoadjuvant Chemoradiotherapy in Patients With Esophageal Cancer Using
Borggreve AS; Goense L; van Rossum PSN; Heethuis SE; van Hillegersberg R; Lagendijk JJW; Lam MGEH; van Lier ALHMW; Mook S; Ruurda JP; van Vulpen M; Voncken FEM; Aleman BMP; Bartels-Rutten A; Ma J; Fang P; Musall BC; Lin SH; Meijer GJ
Int J Radiat Oncol Biol Phys; 2020 Apr; 106(5):998-1009. PubMed ID: 31987972
[TBL] [Abstract][Full Text] [Related]
3. [Pretherapeutic misclassification of esophageal cancer and adenocarcinoma of the esophagogastric junction : Possibilities and clinical consequences].
Gockel I; Lordick F; Lyros O; Kreuser N; Hölscher AH; Wittekind C
Chirurg; 2020 Jan; 91(1):41-50. PubMed ID: 31372677
[TBL] [Abstract][Full Text] [Related]
4. Preoperative image-guided identification of response to neoadjuvant chemoradiotherapy in esophageal cancer (PRIDE): a multicenter observational study.
Borggreve AS; Mook S; Verheij M; Mul VEM; Bergman JJ; Bartels-Rutten A; Ter Beek LC; Beets-Tan RGH; Bennink RJ; van Berge Henegouwen MI; Brosens LAA; Defize IL; van Dieren JM; Dijkstra H; van Hillegersberg R; Hulshof MC; van Laarhoven HWM; Lam MGEH; van Lier ALHMW; Muijs CT; Nagengast WB; Nederveen AJ; Noordzij W; Plukker JTM; van Rossum PSN; Ruurda JP; van Sandick JW; Weusten BLAM; Voncken FEM; Yakar D; Meijer GJ;
BMC Cancer; 2018 Oct; 18(1):1006. PubMed ID: 30342494
[TBL] [Abstract][Full Text] [Related]
5. Editorial on "Can CT-PET and endoscopic assessment post-neoadjuvant chemoradiotherapy predict residual disease in esophageal cancer".
Liu CJ; Lu W
J Thorac Dis; 2017 Oct; 9(10):3645-3648. PubMed ID: 29268364
[No Abstract] [Full Text] [Related]
6. FDG-PET/CT lymph node staging after neoadjuvant chemotherapy in patients with adenocarcinoma of the esophageal-gastric junction.
Fencl P; Belohlavek O; Harustiak T; Zemanova M
Abdom Radiol (NY); 2016 Nov; 41(11):2089-2094. PubMed ID: 27405645
[TBL] [Abstract][Full Text] [Related]
7. The role of PET and PET-CT scanning in assessing response to neoadjuvant therapy in esophageal carcinoma.
Schröer-Günther M; Scheibler F; Wolff R; Westwood M; Baumert B; Lange S
Dtsch Arztebl Int; 2015 Aug; 112(33-34):545-52. PubMed ID: 26356551
[TBL] [Abstract][Full Text] [Related]
8. Neoadjuvant treatment for advanced esophageal cancer: response assessment before surgery and how to predict response to chemoradiation before starting treatment.
Bollschweiler E; Hölscher AH; Schmidt M; Warnecke-Eberz U
Chin J Cancer Res; 2015 Jun; 27(3):221-30. PubMed ID: 26157318
[TBL] [Abstract][Full Text] [Related]
9. Imaging strategies in the management of oesophageal cancer: what's the role of MRI?
van Rossum PSN; van Hillegersberg R; Lever FM; Lips IM; van Lier AL; Meijer GJ; van Leeuwen MS; van Vulpen M; Ruurda JP
Eur Radiol; 2013 Jul; 23(7):1753-65. PubMed ID: 23404138
[TBL] [Abstract][Full Text] [Related]
10. Application of metabolic PET imaging in radiation oncology.
Zhu A; Marcus DM; Shu HK; Shim H
Radiat Res; 2012 Apr; 177(4):436-48. PubMed ID: 22339451
[TBL] [Abstract][Full Text] [Related]
11. Levels of evidence in endoscopic ultrasonography: a systematic review.
Fusaroli P; Kypraios D; Eloubeidi MA; Caletti G
Dig Dis Sci; 2012 Mar; 57(3):602-9. PubMed ID: 22057240
[TBL] [Abstract][Full Text] [Related]
12. Can ¹⁸F-fluorodeoxyglucose positron emission tomography predict responses to neoadjuvant therapy in oesophageal cancer patients? A meta-analysis.
Chen YM; Pan XF; Tong LJ; Shi YP; Chen T
Nucl Med Commun; 2011 Nov; 32(11):1005-10. PubMed ID: 21886014
[TBL] [Abstract][Full Text] [Related]
13. Response monitoring of neoadjuvant therapy using CT, EUS, and FDG-PET.
Sloof GW
Best Pract Res Clin Gastroenterol; 2006; 20(5):941-57. PubMed ID: 16997171
[TBL] [Abstract][Full Text] [Related]
14. The accuracy of endoscopic ultrasonography with fine-needle aspiration, integrated positron emission tomography with computed tomography, and computed tomography in restaging patients with esophageal cancer after neoadjuvant chemoradiotherapy.
Cerfolio RJ; Bryant AS; Ohja B; Bartolucci AA; Eloubeidi MA
J Thorac Cardiovasc Surg; 2005 Jun; 129(6):1232-41. PubMed ID: 15942562
[TBL] [Abstract][Full Text] [Related]
15. Role of positron emission tomography in the (re-)staging of oesophageal cancer.
Westerterp M; Van Westreenen HL; Sloof GW; Plukker JT; Van Lanschot JJ
Scand J Gastroenterol Suppl; 2006; (243):116-22. PubMed ID: 16782630
[TBL] [Abstract][Full Text] [Related]
16. Assessment of response to neoadjuvant therapy in esophageal cancer: an updated systematic review of diagnostic accuracy of endoscopic ultrasonography and fluorodeoxyglucose positron emission tomography.
Ngamruengphong S; Sharma VK; Nguyen B; Das A
Dis Esophagus; 2010 Apr; 23(3):216-31. PubMed ID: 19515185
[TBL] [Abstract][Full Text] [Related]
17. Esophageal cancer: CT, endoscopic US, and FDG PET for assessment of response to neoadjuvant therapy--systematic review.
Westerterp M; van Westreenen HL; Reitsma JB; Hoekstra OS; Stoker J; Fockens P; Jager PL; Van Eck-Smit BL; Plukker JT; van Lanschot JJ; Sloof GW
Radiology; 2005 Sep; 236(3):841-51. PubMed ID: 16118165
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
